Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Recent progress in AML with recurrent genetic abnormalities.

International journal of hematology - 1 Nov 2024

Ishikawa Yuichi

Abstract excerpt

Acute myeloid leukemia (AML) is a heterogeneous disease characterized by various molecular abnormalities that significantly impact its pathogenesis and prognosis. Currently, the prognosis of AML patients is stratified on the basis of co-existing chromosomal and genetic abnormalities. AML patients with NPM1 or CEBPA mutations, which are frequently identified in cytogenetically normal AML, are classified in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CCAAT-Enhancer-Binding Proteins
Share to fms-Like Tyrosine Kinase 3
Share to Leukemia, Myeloid, Acute

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Targeted Therapy

Share to Mutation

Share to Nuclear Proteins

Share to Nucleophosmin

Share to Prognosis

Source

Identifiers

PMID: 39352624
DOI: 10.1007/s12185-024-03848-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Recent progress in AML with recurrent genetic abnormalities.PMID 39352624Read ↗

A concise review on the molecular genetics of acute myeloid leukemia.Semantic proximity Read ↗

Genetic abnormalities in acute myelogenous leukemia with normal cytogenetics.Semantic proximity Read ↗

Emerging molecular predictive and prognostic factors in acute myeloid leukemia.Semantic proximity Read ↗

New molecular abnormalities and clonal architecture in AML: from reciprocal translocations to whole-genome sequencing.Semantic proximity Read ↗

Molecular Mutations and Their Cooccurrences in Cytogenetically Normal Acute Myeloid LeukemiaSemantic proximity Read ↗

‘Acute myeloid leukemia: a comprehensive review and 2016 update’Semantic proximity Read ↗

Mutational landscape of AML with normal cytogenetics: biological and clinical implications.Semantic proximity Read ↗

Molecular prognostic factors in cytogenetically normal acute myeloid leukemia.Semantic proximity Read ↗

Management of patients with cytogenetically normal acute myeloid leukemia who have neither favorable nor unfavorable markers.Semantic proximity Read ↗

Impact of genomics in the clinical management of patients with cytogenetically normal acute myeloid leukemia.Semantic proximity Read ↗

Prognosis and treatment in acute myeloid leukemia: a comprehensive reviewSemantic proximity Read ↗

Acute Myeloid Leukemia With Recurrent Genetic Abnormalities Other Than Translocations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.